Search Results - "Post, H.C."

The narrow road to expanded access by Post, H.C., Schutte, T., Voortman, J., Bartelink, I.H., van Laarhoven, H.W.M., Crul, M.

Get full text

Time to reimbursement of novel anticancer drugs in Europe: a case study of seven European countries by Post, H.C., Schutte, T., van Oijen, M.G.H., van Laarhoven, H.W.M., Hollak, C.E.M.

“…Time to reimbursement (TTR) of new anticancer medicines differs between countries and contributes to unequal access. We aimed to investigate TTR of new…”
Get full text

Effect of a prediction tool and communication skills training on communication of treatment outcomes: a multicenter stepped wedge clinical trial (the SOURCE trial)Research in context by L.F. van de Water, S.C. Kuijper, I. Henselmans, E.N. van Alphen, E.S. Kooij, M.M. Calff, L.V. Beerepoot, J. Buijsen, W.J. Eshuis, E.D. Geijsen, S.H.C. Havenith, F.F.B.M. Heesakkers, S. Mook, K. Muller, H.C. Post, H. Rütten, M. Slingerland, T. van Voorthuizen, H.W.M. van Laarhoven, E.M.A. Smets

“…Background: For cancer patients to effectively engage in decision making, they require comprehensive and understandable information regarding treatment options…”
Get full text

Effect of a prediction tool and communication skills training on communication of treatment outcomes: a multicenter stepped wedge clinical trial (the SOURCE trial) by van de Water, L.F., Kuijper, S.C., Henselmans, I., van Alphen, E.N., Kooij, E.S., Calff, M.M., Beerepoot, L.V., Buijsen, J., Eshuis, W.J., Geijsen, E.D., Havenith, S.H.C., Heesakkers, F.F.B.M., Mook, S., Muller, K., Post, H.C., Rütten, H., Slingerland, M., van Voorthuizen, T., van Laarhoven, H.W.M., Smets, E.M.A.

“…For cancer patients to effectively engage in decision making, they require comprehensive and understandable information regarding treatment options and their…”
Get full text